Antitumoral Activity of the Novel BTK Inhibitor TG-1701 is Associated with Disruption of Ikaros Signaling and Improvement of Anti-CD20 Therapy in B-cell Non-Hodgkin Lymphoma

Drug Category: Array
Conference Category: Array
Lead Author: Roue G, et al.
Published Date: 18/06/2021
Download Link: /wp-content/uploads/2021/06/ICML21-Poster-TG-1701-Preclinical-Roue-FINAL-PDF-6.18.21.pdf
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top